The MedicX Fund Limited Allotment of scrip shares to Directors (9739J)

TIDMMXF

RNS Number : 9739J

The MedicX Fund Limited

03 July 2017

For immediate release

3 July 2017

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Allotment of scrip shares to Directors

and Investment Adviser and total voting rights

Members of the Company's Board of Directors elected to participate in the Company's scrip dividend scheme in respect of the June 2017 dividend for the quarter ended 31 March 2017, and accordingly acquired ordinary shares of no par value in the Company (the "Shares") as disclosed in the table below.

 
                   Shares      Total    Percentage 
                   Acquired    Shares     Holding 
                                Held 
 David Staples 
  (Chairman)          1,573    96,369   0.022% 
 Shelagh Mason          526    32,249   0.008% 
 John Hearle            514    31,472   0.007% 
 Helen Mahy            -(*)    28,604   0.007% 
 

(*) Helen Mahy did not elect to participate in the scrip dividend scheme in respect of the June 2017 dividend.

The Shares were acquired on 30 June 2017 and rank pari passu with the Company's existing ordinary shares.

The Directors detailed above, who elected to participate in the Company's scrip dividend scheme, did so under an election mandate which remains in place until revoked.

Octopus Healthcare Adviser Ltd (the Company's Investment Adviser) also elected to participate in the Company's scrip dividend scheme in respect of the June 2017 dividend for the quarter ended 31 March 2017, and accordingly was allotted 36,919 ordinary shares of no par value in the Company (the "Shares"). The Shares were sold out of treasury at the previously advised scrip calculation price of 90.3 pence per share.

The acquisition of the Shares brings Octopus Healthcare Adviser Ltd's total holding in the Company to 2,259,489 shares, representing 0.53% of the Company's total voting rights. The Shares were acquired on 30 June 2017 and rank pari passu with the Company's existing ordinary shares.

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of the Company in issue as at 30 June 2017 was 428,530,249 (excluding treasury shares) with each share holding one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

The Company also holds 7,472,150 ordinary shares in treasury.

Copies of the documents relating to the Scrip Dividend Alternative are available for inspection through the National Storage Mechanism (http://www.morningstar.co.uk/uk/NSM).

End

For further information please contact:

   MedicX Fund                                                                  [phone] 

David Staples, Chairman

   Octopus Healthcare Group                                               [phone] 

Mike Adams, Chief Executive Officer

   Buchanan                                                                      [phone] 

Charles Ryland/Vicky Hayns

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", "MedicX Fund", "the Fund" or "the Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 157 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is part of the Octopus Healthcare group. Octopus Healthcare invests in and develops properties as well as creating partnerships to deliver innovative healthcare buildings to improve the health, wealth and wellbeing of the UK. It currently manages over GBP1 billion of healthcare investments across a number of platforms, with a focus on five core areas: GP surgeries, care homes, special education schools, retirement housing and private hospitals. Octopus Healthcare is part of the Octopus group, a fast-growing UK fund management business with leading positions in several specialist sectors including healthcare property, energy, property finance and smaller company investing. Octopus manages GBP6 billion of funds for more than 50,000 retail and institutional investors.

Octopus Healthcare Adviser Ltd is authorised and regulated by the Financial Conduct Authority.

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

The Company's Legal Entity Identifier is 2138008POF35FTNFCB25

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCKMGGNDFRGNZM

(END) Dow Jones Newswires

July 03, 2017 11:02 ET (15:02 GMT)